A 58-gene pan-cancer panel with combined DNA content, utilizing the single-tube SLIMamp™ workflow for fast library prep and turnaround time.
Assay time
Hands-on time
Input quantity
The oncoReveal™ Myeloid Panel is a DNA NGS sequencing panel using proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp®) technology, a tiled amplicon-based library prep chemistry for efficient single-tube target enrichment.
| Assay time | ~6.5 hr |
|---|---|
| Cancer type | Pan-Cancer, Solid Tumor |
| Description | 58-gene amplicon based DNA panel, simple single tube workflow |
| Hands-on time | ~3 hr |
| Input quantity | 10ng - 80ng DNA (20ng recommended) |
| Instruments | MiSeq System, NextSeq 550 System, MiSeqDx in Research Mode, NextSeq 550Dx in Research Mode |
| Mechanism of action | Multiplex PCR using tiled amplicon |
| Method | Amplicon Sequencing, Targeted DNA Sequencing |
| Nucleic acid type | DNA |
| Number of amplicons | 1 pool, 766 amplicons |
| Number of reactions | 24 reactions |
| On-target reads | 99.6% ± 0.2% |
| Specialized sample types | Blood, Low-Input Samples |
| Species category | Human |
| Target insert size | Average: 215 bp |
| Technology | Sequencing |
| Uniformity | 96.8% ±1.0% |
| Variant class | Single nucleotide variants (SNVs), Insertions-deletions (indels), Copy number variants (CNVs) |
Pillar® oncoReveal™ panels require the use of a Pillar index kit. Pick your preferred number of reactions.
Pillar® oncoReveal™ Myeloid Panel
Literature is not currently available for this product.
A dedicated support section is not currently available for this product
| Pillar® oncoReveal™ Myeloid Panel | AmpliSeq for Illumina Myeloid Panel | TruSight Myeloid Sequencing Panel | |
|---|---|---|---|
| Assay time | ~6.5 hr | ||
| Cancer type | Pan-Cancer, Solid Tumor | ||
| Description | 58-gene amplicon based DNA panel, simple single tube workflow | ||
| Hands-on time | ~3 hr | ||
| Input quantity | 10ng - 80ng DNA (20ng recommended) | ||
| Instruments | MiSeq System, NextSeq 550 System, MiSeqDx in Research Mode, NextSeq 550Dx in Research Mode | ||
| Mechanism of action | Multiplex PCR using tiled amplicon | ||
| Method | Amplicon Sequencing, Targeted DNA Sequencing | ||
| Nucleic acid type | DNA | ||
| Number of amplicons | 1 pool, 766 amplicons | ||
| Number of reactions | 24 reactions | ||
| On-target reads | 99.6% ± 0.2% | ||
| Specialized sample types | Blood, Low-Input Samples | ||
| Species category | Human | ||
| Target insert size | Average: 215 bp | ||
| Technology | Sequencing | ||
| Uniformity | 96.8% ±1.0% | ||
| Variant class | Single nucleotide variants (SNVs), Insertions-deletions (indels), Copy number variants (CNVs) |
oncoReveal™ Myeloid Panel
HDA-MY-1001-24
oncoReveal™ Myeloid Panel
Indices PI501-8, PI701-4 (32 combinations, 96 reactions)
IDX-PI-1001-96
Indices PI501-8, PI701-4 (32 combinations, 96 reactions)
Kit D, indices PI501-8, PI701-12
IDX-PI-1004-192
Kit D, indices PI501-8, PI701-12
Showing of
Product
Qty
Unit Price
Product
Catalog ID
Quantity
Unit price
Advanced chemistry, optics, and informatics combine to deliver exceptional speed and data quality, outstanding throughput and scalability.
Optimized chemistry to increase cluster density and read length, and improve sequencing quality scores, compared to earlier MiSeq reagent kit versions.
Enable CGP with a large pan-cancer panel covering all major variant classes plus gene signatures (TMB, MSI, and HRD) from FFPE tissue.
A fast, integrated workflow for a wide range of applications, from human whole-genome sequencing to amplicons, plasmids, and microbial species.
Reach out for information about our products and services, or get answers to questions about our technology.
Your email address is never shared with third parties.
